Meilleurs médecins de cancer du foie stade 4 à l'étranger — Page 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Le Dr Alexander Beny dirige le service des tumeurs malignes gastro-intestinales au centre médical Rambam, se spécialisant dans les cas avancés de cancer du foie.

• Oncologue certifié avec une formation approfondie en oncologie médicale et en radiothérapie
• Directeur des services d'oncologie gastro-intestinale dans un grand hôpital israélien
• A suivi une formation spécialisée dans les techniques modernes de curiethérapie
• Parle couramment l'anglais et l'hébreu pour les patients internationaux

Le Dr Maha Yahia est oncologue médicale et hématologue aux hôpitaux oncologiques internationaux Shefaa Al Orman. Elle a servi en tant que médecin avec le grade de lieutenant-colonel dans le corps médical des forces armées égyptiennes. Le Dr Yahia est spécialisée dans la planification du traitement des cancers du sein, du thorax et gastro-intestinaux. Elle se concentre sur l'immunothérapie, la thérapie ciblée et les protocoles de chimiothérapie complexes.

• Ancienne chef de l'équipe de soutien à la recherche clinique au Maadi AFMC.
• Formée à l'Institut national du cancer de l'Université du Caire en hémato-oncologie.
• Traite les cancers génito-urinaires, gynécologiques et rares, ainsi que les affections hématologiques.
• Travaille dans un centre accrédité par l'ESMO qui traite 6 000 patients par an.

Spécialisé dans les chirurgies complexes du cancer, y compris les interventions sur le foie, le pancréas et les voies biliaires dans les hôpitaux Büyük Anadolu.

• Expert en chirurgie oncologique axée sur les cancers gastro-intestinaux
• Réalise des chirurgies bariatriques et métaboliques avancées
• Compétent dans les opérations du cancer du sein et de la thyroïde

Dr. Brenda Pastrana est une chirurgienne oncologue certifiée spécialisée dans le cancer du foie à l'hôpital Galenia.

• Membre de la Société Mexicaine d'Oncologie
• Enseignante universitaire à l'Universidad Anahuac depuis 2020
• Diplômée de l'Université Nationale Autonome du Mexique (UNAM)
• Formée en tant que chirurgienne oncologue au Centro Medico Nacional 20 de Noviembre

La Prof. Elke Jaeger est une oncologue de premier plan en Allemagne avec 41 années d'expérience, spécialisée dans le cancer du foie avancé à la clinique Nordwest.

• Chef du service d'oncologie et d'hématologie à la clinique Nordwest
• A réalisé plus de 1 100 procédures oncologiques
• Classée parmi les meilleurs oncologues d'Allemagne depuis 41 années
• Professeure d'oncologie médicale et d'hématologie
• Membre de l'Organisation européenne pour la recherche et le traitement du cancer (EORTC)

Le Dr Topcu a suivi une formation au MD Anderson Cancer Center et se spécialise dans le cancer du foie, parmi d'autres domaines de l'oncologie. Elle apporte une vaste expertise internationale à sa pratique au sein de l'hôpital universitaire Biruni.

• Oncologue médicale certifiée avec plus de _doctor_9372_ années d'expérience
• Membre de la Société européenne d'oncologie médicale (ESMO)
• Formée dans des centres de cancérologie de premier plan aux États-Unis et au Canada
• Spécialisée dans les cancers gastro-intestinaux complexes, y compris le cancer du foie

Le Dr Atakan Topcu est oncologue médical à l'hôpital Medipol Acibadem District d'Istanbul. Il est spécialisé dans le traitement des tumeurs solides, notamment les cancers du poumon, du sein et colorectal. Le Dr Topcu est professeur associé et auteur de plus de 50 publications scientifiques évaluées par des pairs. Il siège au comité de rédaction de la revue médicale BMC Cancer.

• Expertise en immunothérapie, thérapies ciblées et oncologie gériatrique.
• Traite la dénutrition liée au cancer, la cachexie et la sarcopénie.
• Membre actif de la Société européenne d'oncologie médicale (ESMO).
• Travaille dans un hôpital accrédité par la JCI, spécialisé dans les traitements oncologiques avancés.

Le Dr Ayşe İrem Yasin est oncologue médical à l'hôpital de district Medipol Acıbadem à Istanbul. Elle détient le prestigieux certificat du conseil de l'ESMO. Le Dr Yasin est spécialisée dans les tumeurs solides, notamment les cancers du sein, du poumon et gastro-intestinaux. Elle traite des cas complexes tels que le carcinome à cellules de Merkel et les cancers de primitif inconnu.

• Formée à la Harvard Medical School, à la Cleveland Clinic et à l'hôpital universitaire de Bâle.
• A effectué un stage d'observation clinique dans l'unité de cancer du sein à Novare, en Italie.
• Traite les tumeurs malignes du cerveau et du SNC, les sarcomes des tissus mous et les cancers urologiques.
• Travaille dans un établissement accrédité par la JCI et équipé du système robotique da Vinci.

La professeure Gul Alco est spécialisée en radio-oncologie à l'hôpital Medipol Acibadem, avec plus de _doctor_7679_années_ d'expérience dans le domaine.

• Professeure au département de radio-oncologie de l'Université Medipol d'Istanbul
• A terminé sa résidence à la faculté de médecine de l'Université Kadir Has
• Maître de conférences puis professeure à l'Université Demiroglu Bilim
• A travaillé à l'hôpital Şişli Florence Nightingale et à l'hôpital Gayrettepe Florence Nightingale

Nail Paksoy apporte une vaste expérience acquise à l'Institut d'oncologie de l'Université d'Istanbul et occupe actuellement le poste de professeur associé à l'hôpital Medipol Bahçelievler.

• Spécialisé dans le traitement du cancer du foie avec un accent sur les stades avancés
• Certifié en oncologie médicale par l'ESMO
• A contribué à huit essais cliniques internationaux en oncologie
• A publié de nombreux articles de recherche sur les cancers métastatiques

Le Dr Kopchak est spécialisé dans le cancer du foie, alliant pratique clinique et recherche de pointe à l'Institut national du cancer.

• Plus de 30 articles scientifiques publiés dans des revues indexées par Scopus
• Co-auteur de plus de 170 travaux de recherche et 2 monographies
• Chercheur principal dans un institut chirurgical ukrainien de premier plan
• Se concentre sur les stratégies de diagnostic et de traitement chirurgical

Avec plus de _doctor_2687_années_ d'expérience chirurgicale, le Dr Ugur Ekici, professeur associé, est spécialisé dans la chirurgie laparoscopique avancée et la chirurgie oncologique à l'hôpital Medicana Bahcelievler.

• Formation spécialisée à la clinique de chirurgie générale de l'hôpital Şişli Etfal
• Expertise dans les procédures oncologiques standard et mini-invasives
• Recherches publiées dans des revues médicales internationales

Le Pr Ersin Ozturk apporte une vaste expertise en oncologie chirurgicale et en chirurgie gastro-intestinale à l'hôpital Medicana Bursa.

• Professeur de médecine avec plus de 28 années d'expérience
• Spécialisé en chirurgie laparoscopique et bariatrique
• Bourse de recherche à la Cleveland Clinic Foundation
• Membre de plusieurs sociétés chirurgicales

Le Prof. Engin apporte des décennies d'expertise spécialisée en radio-oncologie, y compris une formation avancée au National Cancer Institute et à l'Université Thomas Jefferson.

• Ancien président de radio-oncologie à l'Université d'Uludag
• A dirigé des programmes de radio-oncologie dans plusieurs hôpitaux de premier plan
• Spécialisé dans les techniques de thermoradiothérapie
• Titulaire d'une bourse de recherche du National Cancer Institute

Le Dr Sridhar P.S. est spécialisé en radiothérapie pour le cancer du foie au HCG Manavata Cancer Centre, avec une formation approfondie en oncologie.

• Plus de _doctor_3397_ années d'expérience en radiothérapie
• Diplômé du Conseil national en radiothérapie
• Membre de l'Association d'oncologie radiothérapique de l'Inde
• Spécialisé en neuro-oncologie et en oncologie par hyperthermie